Drug Profile
NCX 1101
Latest Information Update: 24 Jun 2001
Price :
$50
*
At a glance
- Originator NicOx
- Class
- Mechanism of Action Cyclooxygenase inhibitors; Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Colorectal cancer
Most Recent Events
- 24 Jun 2001 Discontinued-Preclinical for Colorectal cancer in France (Unknown route)
- 05 Nov 1998 New profile
- 05 Nov 1998 Preclinical development for Colorectal cancer in France (Unknown route)